MARX Biotech Co., Ltd. (TPEX:7731)
3.640
-0.310 (-7.85%)
Nov 20, 2026, 1:49 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 1.9 billion as of November 20, 2026. It is the 28,467th most valuable company in the world and the 1,562nd biggest in Taiwan. Its market cap has decreased by 23.99% in one year.
Market Cap
1.90B
Enterprise Value
2.05B
Revenue
584.74M
Global Rank
Country Rank
#1,562 Taiwan
PE Ratio
60.27
ChartMarket Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 1.90B, a decrease of -56.65%. That is a compound annual growth rate of -25.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.97B | -19.31% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 499.39B |
| Lin BioScience | 125.62B |
| Caliway Biopharmaceuticals | 111.37B |
| Heron Neutron Medical | 68.33B |
| BIONET | 2.13B |
| MedFirst Healthcare Services | 2.10B |
| GlycoNex Incorporation | 2.09B |
| Merdury Biopharmaceutical | 2.09B |